yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q28082059-DD4078C9-FEF2-4C23-AC50-AB0DDF082AF2
Q28082059-DD4078C9-FEF2-4C23-AC50-AB0DDF082AF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082059-DD4078C9-FEF2-4C23-AC50-AB0DDF082AF2
The potential for emerging therapeutic options for Clostridium difficile infection
P2860
Q28082059-DD4078C9-FEF2-4C23-AC50-AB0DDF082AF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082059-DD4078C9-FEF2-4C23-AC50-AB0DDF082AF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
df7e35c1de603083d72df4218d6af4000c85d884
P2860
Fidaxomicin versus vancomycin for Clostridium difficile infection.